METTL7B is a novel prognostic biomarker of lower-grade glioma based on pan-cancer analysis

METTL7B is a novel prognostic biomarker of lower-grade glioma based on pan-cancer analysis

Abstract Methyltransferase-like 7B (METTL7B) is a member of the methyltransferase-like protein family that plays an important role in the development and progression of tumors. However, its prognostic value and the correlation of METTL7B expression and tumor immunity in some cancers remain unclear....

Full description

Bibliographic Details
Main Authors: Zhipeng Jiang, Wen Yin, Hecheng Zhu, Jun Tan, Youwei Guo, Zhaoqi Xin, Quanwei Zhou, Yudong Cao, Zhaoping Wu, Yirui Kuang, Can Li, Dongcheng Xie, Hailong Huang, Ming Zhao, Xingjun Jiang, Lei Wang, Caiping Ren
Format: Article
Language:English
Published: BMC 2021-07-01
Series:Cancer Cell International
Subjects:
Glioma
Methyltransferase-like 7B
Pan-cancer analysis
Prognostic markers
Epithelial–mesenchymal transition (EMT)
Immune cell infiltration
Online Access:https://doi.org/10.1186/s12935-021-02087-4

Internet

https://doi.org/10.1186/s12935-021-02087-4

Similar Items